The hormone adrenomedullin disrupts insulin signaling in blood vessel cells, contributing to systemic insulin resistance in obesity-associated type 2 diabetes, according to a new study.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback